Misoprostol and the debate over off-label drug use.
Weeks
Andrew D
AD
University of Liverpool, Liverpool Women's Hospital, UK.
Fiala
Christian
C
Safar
Peter
P
D000020:Abortifacient Agents, Nonsteroidal; D000028:Abortion, Induced / Q000379:methods; D000349:Africa / Q000453:epidemiology; D000075202:Contraindications; D017277:Drug Approval; D004345:Drug Industry; D004348:Drug Labeling; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D007751:Labor, Induced / Q000009:adverse effects*; D008428:Maternal Mortality; D016595:Misoprostol; D010120:Oxytocics; D011247:Pregnancy
D000020:Abortifacient Agents, Nonsteroidal; D010120:Oxytocics; D016595:Misoprostol